RPL18AP15

Across TCGA pan-cancer cohorts, RPL18AP15 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPL18AP15’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL18AP15 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL18AP15 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

COAD, LIHC, and KIRC are the cancer types where RPL18AP15 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL18AP15 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.216	.002	9	view →
LIHC	Female	II,III,IV	+0.114	.002	4	view →
KIRC	All	All	+0.054	.004	3	view →
LUSC	Female	III,IV	+0.185	.006	2	view →
THCA	All	All	−0.055	.010	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RPL18AP15–COAD

Open the COAD breakdown →